ClinicalTrials.govpublic full text
Open Label Study to Assess the Predictability of Early Response to Certolizumab Pegol in Patients With Rheumatoid Arthritis
rheumatoid arthritis, certolizumab pegol - cimzia, power doppler ultrasonography, italy, moderate-severe rheumatoid arthritis, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 833155
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.